Cudrania tricuspidata is a plant used in folk medicine in Korea for treatment of diseases related to oxidative stress and inflammation. In this study the leaf and shoot extract was studied for its antioxidant, anti-inflammatory, and xanthine oxidase (XO) inhibitory activities. The extract with predominant phenolics was quantified using HPLC-DAD. Antioxidant activity was measured using ABTS [2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) and FRAP (ferric ion reducing antioxidant power), and anti-inflammatory activity by diene-conjugate and β-glucuronidase assays. The average antioxidant effects of C. tricuspidata extracts (1-2 mg/mL) revealed significant activity of 32.5% to 50.2% (ABTS) and 24.2 to 40.5% (FRAP) compared with Trolox, having 55.1% (ABTS) and 42.6% (FRAP) activity, respectively. The anti-inflammatory activities showed as 26.5% to 40.5% (DC) and 40.2% to 70.2% (βG) inhibition compared with the control {phenylbutazone; 42.1% (DC) and 80.2% (βG) inhibition, respectively}. The XO inhibitory activity of the plant extract revealed 90.5% inhibition of that of the control (allopurinol) (97% inhibition at 100 µg/mL concentration). The kinetic parameters of XO inhibition revealed a noncompetitive type of inhibition, where, K m and V max of C. tricuspidata extracts (25 to 100 µg/mL) were 0.25 mM/mL and 0.040, 0.036, 0.032, and 0.030 (µg/min), while for the positive control K m and V max the values were 0.30 mM/mL and 0.045 (µg/min), respectively. Results suggest that C. tricuspidata can be exploited against diseases associated with free radical formation and xanthine oxidase activity.
Cudrania tricuspidata (Carr) Bur is a deciduous plant distributed across Korea, China, and Japan; this plant is widely used as a folk medicine in Korea for treatment of diseases related to oxidative stress, and inflammation [1, 2] . C. tricuspidata roots have been used for the treatment of digestive tract tumors, especially gastric carcinoma, aside from its use for the treatment of gonorrhea, rheumatism, jaundice, boils, scabies, bruising and dysmenorrhea [3, 4] . Therefore, the roots of C. tricuspidata represent a valuable source of natural products that could be used as antitumor drugs. The cortex and root bark of this species have been used as a traditional medicine for the treatment of neuritis and inflammation [5] . Moreover, the roots and bark have been used as a traditional Chinese medicine for the treatment of lumbago, hemoptysis, and contusions [6] . C. tricuspidata has become one of the most important folk remedies for treatment of cancer in Korea during the past few decades, and also it has shown potent activities towards oxidative stress, free radical generation and inflammation [7] . However, the research on effective constituents from the roots has mainly been focused on small-molecular compounds, especially xanthones and flavonoids [8] . In previous studies, cytotoxic [9] , antioxidant [10] , anti-atherosclerotic, anti-inflammatory [11] , and hepatoprotective [12] prenylated flavonoids and xanthones were isolated from the root bark of C. tricuspidata. The fruits of this plant also contain carotenoids [13] , prenylated isoflavonoids, and benzylated flavonoids, all showing anti-inflammatory and monoamine oxidase inhibitory activities [14] . A compound called cudratricusxanthone A (CTXA), isolated from the roots of C. tricuspidata, has potent biological and oxidase inhibitory effects [12, 15] . CTXA can also scavenge oxygen radicals such as hydroxyl and superoxide [16] . Several previous research reports have suggested roles of C. tricuspidata extract, including various biological activities [8] [9] [10] [11] [12] , inhibitory effects on nitric oxide synthase (NOS) [17] , and on proliferation of inflammatory immune and tumor cells [18] . The major constituents of C. tricuspidata fruits have been identified as prenylated isoflavonoids such as 6,8-diprenylorobol, 6,8-diprenylgenistein, and 4 ' -O-methylalpinumisoflavone [19] . Considering the medicinal importance of C. tricuspidata, this study was aimed at evaluation of the effect of extracts with antioxidant, anti-inflammatory, and xanthine oxidase inhibitory analysis.
HPLC analysis of C. tricuspidata aqueous extract revealed twelve main peaks in the extract at 280 nm. These data strongly suggest the predominance of phenolic compounds such as flavonoids and tannins, which present characteristic bands at this wavelength.
The ABTS and FRAP radical scavenging activity for C. tricuspidata extracts is summarized in Table 1 . The results revealed that the extract of the root and shoot were effective in both assays. The overall range of ABTS and FRAP scavenging activity of C. tricuspidata extracts (1-2 mg/mL) revealed significant activity of 32.5% to 50.2% (ABTS) and 24.2 to 40.5% (FRAP) compared with Trolox, having 55.1% (ABTS) and 42.6% (FRAP) activity, respectively. The average activity with antioxidant capacities of plant extracts not only relies on plant composition, but also on the conditions of the test used. Several methods are used for measuring total antioxidant capacity in vitro; these are classified into two types, those based on hydrogen atom transfer (HAT) and those on electron transfer (ET). HAT-based methods apply a competitive reaction scheme in which antioxidant and substrate compete for thermally generated peroxyl radicals [20] . The capacity of an antioxidant to reduce an oxidant, which changes color when reduced, is measured in ET-based assays. The degree of color change is correlated with the sample's antioxidant concentration [21] . There is no single method that can prove that a drug is a strong antioxidants; more than one type of antioxidant assay needs to be performed to take into account the various modes of action of antioxidants [22] . In this study, we determined the free radical scavenging capacities of C. tricuspidata extract using ABTS, and its ferric reducing capacities using the FRAP assay. These assays have Nile & Kim been widely used to determine the antioxidant capacities of plant extracts as they require relatively standard equipment and deliver fast and reproducible results. Indeed, an inter laboratory comparison of antioxidant methods for measuring antioxidant potential published recently showed that ABTS assays are the easiest to implement and yield the most reproducible results [23] . The ABTS and FRAP assays gave comparable results for the antioxidant activity measured in C. tricuspidata extract. Values represent Mean ± S.E from three experiments Anti-inflammatory activity was determined by using dieneconjugate and β-glucuronidase assays ( Table 2 ). The C. tricuspidata extract revealed an excellent anti-inflammatory activity profile showing 58.2 and 68.4% inhibition, which is comparable with that of the control showing inhibition percentages of 50 and 72%, respectively. The results presented here for the extract of C. tricuspidata revealed excellent anti-inflammatory activity. It is known that during inflammation and associated processes, there is an increased production of superoxide ions, which might be inhibited by possible anti-inflammatory mechanisms with the help of C. tricuspidata extract and its bioactive compounds by inhibiting superoxide generation in peritoneal macrophages [23, 24] . β-Glucuronidase mainly occurs in lysosomes of neutrophils and plays an important role as a mediator in the initiation and progression of inflammation [21, 22] . The intermediate step in membrane lipid peroxidation is the generation of hydroperoxides (dieneconjugates), which lead to development of oxidative stress in cells [23, 24] . The lipid peroxidation phenomenon plays a vital role in many inflammatory disorders. The lipid peroxidation results in oxidative modifications of the apoprotein, which is mainly involved in macrophage uptake and atherogenesis [7, 11] . The result indicates that C. tricuspidata extract may reduce the lipid peroxidation by means of its antioxidant and anti-inflammatory activity. The inflammatory condition was induced by sodium dodecyl sulfate (50 µg/pellet) and was observed after 24 hours. The phenylbutazone (control) produced 75 to 80% inhibition. However, the C. tricuspidata extract revealed a very weak percentage inhibition by this assay. The C. tricuspidata extracts demonstrated dose dependent XO inhibitory activity at 25, 50, 75 and 100 µg/mL ( Table 3 ). The minimal inhibitory activity was 35.2% at 25 µg/mL and maximum 90.5% at 100 µg/mL, which was approximately similar to that of the standard drug, allopurinol (97%), at 20 µM/mL. The inhibition of XO results in a decreased production of uric acid, measured spectrophotometrically at 295 nm. The significant inhibition of XO by the extract might suppress the production of active oxygen species or uric acid in vivo under the conditions that XO works. The inhibition percentage of C. tricuspidata extract was comparable to that of allopurinol (20 µg /mL), a therapeutic drug used to treat gout. The methanol extract of C. tricuspidata has shown a better Values represent Mean ± S.E from three experiments. characteristic for obtaining a high percentage of XO activity, probably due to the nature of active components like alkaloids, flavonoids, essential oil, and terpenoids,, which may be enhanced by stronger extraction capacity for the active constituents responsible for XO inhibition [24] . Any of these bioactive compounds may contribute to XO inhibitory activity as they have previously received considerable attention because of their physiological functions such as antioxidant, antimutagenic and antitumor activities [25, 26] . The kinetic analysis was studied using a Lineweaver Burk plot; the results revealed that the extract of C. tricuspidata displayed high inhibitory activity towards xanthine oxidase. The pattern of inhibition is non-competitive in the presence of C. tricuspidata extract, where V max is decreased and K m appears to be unaltered with respect to xanthine as substrate ( Figure 1 ). This indicates that binding of the extract may occur with either the free enzyme or the enzyme substrate complex. The significant inhibition of XO by the extract of C. tricuspidata may suppress the production of reactive oxygen species or uric acid in vivo under the conditions that xanthine oxidase works. The inhibition percentage of the extract of C. tricuspidata is comparable with that of allopurinol, a therapeutic drug used to treat gout.
From this study it can be concluded that C. tricuspidata extract exhibits strong antioxidant and anti-inflammatory activity with potent XO inhibition, along with the presence of prominent phenolics, as determined by HPLC. Thus C. tricuspidata might have great potential to act as a free radical scavenger to reduce oxidative stress and inflammation. A bioguided fractionation of C. tricuspidata extract will be being carried out with the aim of formulation of a safer and efficient drug to prevent oxidative stress and related diseases. The data obtained correlate with the ethno botanical data on the use of this species in Korean folklore. material extracted with methanol (90%) using a Soxhlet apparatus for 4 h. The extract was filtered, concentrated to dryness under reduced pressure at 60 0 C in a vacuum rotator evaporator and used for activity measurements [27] .
Experimental

Plant material and preparation of extract
HPLC analysis: HPLC analysis of the C. tricuspidata extract was carried out using an Agilent 1100 chromatograph (Agilent, Palo Alto, CA, USA) equipped with a solvent delivery system, an autosampler, a DAD detector set at 280 nm, and a Chem-Station data acquisition system [28] .
ABTS radical scavenging activity: ABTS {25 mg (5 mM)} was oxidized with potassium persulfate 3.5 mg (2.45 mM) overnight in a dark bottle in the dark. The working solution was then diluted with ethanol to an absorbance of 0.75 at 734 nm. A standard calibration curve was constructed for Trolox at 0, 0.1, 0.2, 0.3, 0.4, 0.5, 1.0, and 2 mM. An aliquot (10 µL) of C. tricuspidata extract (1, 1.5 and 2 mg/mL conc.) was mixed with 1.0 mL of ABTS radical cation working solution in a cuvette and absorbance was read at 734 nm after 30 min. The activity was expressed as the effective concentration of drug necessary to give a 50% reduction in the original absorbance [27] .
Ferric reducing antioxidant power (FRAP) assay:
The stock solutions were prepared using 30 mM acetate buffer (3.5 g sodium acetate trihydrate and 20 mL acetic acid, pH 3.6). The reagent was prepared by using TPTZ in 40 mM HCl and 20 mM FeCl 3 .6H 2 O solution. The fresh working solution was prepared by mixing 25 mL acetate buffer, 2.5 mL TPTZ solution and 2.5 mL FeCl 3 .6H 2 O so as to form the FRAP solution. The working solution (FRAP) was warmed at 37 0 C before use. C. tricuspidata extract at different concentrations (1, 1.5 and 2 mg/mL) was allowed to react with 28.50 µL of the FRAP solution for 30 min in the dark. Absorbance of the colored product (ferrous tripyridyltriazine complex) was recorded at 595 nm. Trolox was used as standard and the standard curve was linear between 25 and 800 µM. The results were expressed as µM Trolox equivalent (TE)/g fresh mass. Additional dilution was needed if the FRAP value measured was over the linear range of the standard curve [29] .
Conjugated diene assay:
The conjugated diene assay involves the preparation of RBC cell membranes. The blood samples were collected with the addition of EDTA (2 mg/mL) as an anticoagulant; this was centrifuged and the plasma aspirated. The blood cells were washed 3 times with saline (0.89%) to 0.5 mL of cells; 7 mL of ice-cold distilled water was added and left overnight at 0 0 C; the hemolysate was separated by centrifugation in a cooling centrifuge at 10,000 rpm for 20 min. The pellet was washed twice with distilled water, followed by centrifugation for 10 min and then suspended in 10 mL of Tris-HCl buffer (0.1 M, pH 7.4); the resultant solution was then used as a membrane solution. The membrane solution (1.0 mL) was mixed with 5 mL of chloroform: methanol (2:1) and 2 g of C. tricuspidata extract. The mixture was centrifuged at 10,000 RPM for 15 min to separate the 2 phases. The chloroform layer was removed and dried at 45 0 C in a water bath.
The lipid residue was dissolved in 1.5 mL of cyclohexane and hydro peroxides generated were detected spectrophotometrically at 233 nm against cyclohexane as blank. Acetylsalicylic acid (1 mM) was used as a standard drug. The percent activity in all the parameters was calculated by using the standard formula; Activity = (1-T/C) X 100, where T and C = absorbance of test and control samples respectively [30, 31] . β-Glucuronidase inhibition assay: For this assay, 2.5 mM p-nitrophenyl-β-D-glucopyranosiduronic acid was incubated with 1 mg (0.1 mL) of C. tricuspidata extract in acetate buffer (0.1M, pH 7.4) for 5 min followed by addition of 0.1 mL of β-glucuronidase solution. The mixture was further incubated for 30 min, followed by addition of 2 mL NaOH (0.5 N) for termination of the reaction. The amount of reaction product formed was observed and absorbance was recorded spectrophotometrically at 410 nm. Salicylic acid (1 mM) was used as reference drug for comparative study [21, 22] .
Xanthine oxidase inhibitory activity:
The inhibitory activity of C. tricuspidata extract was determined using the standard inhibitor allopurinol (5 mM), which was diluted with phosphate buffer (0.1 mM) to obtain 5, 10, 15, 20 and 25 µM solutions. C. tricuspidata extract was dissolved in 1 mM phosphate buffer (pH 7.5) to make concentrations of 25, 50, 75 and 100 µg/mL, The inhibitory activity of C. tricuspidata extract was determined for control and sample as; Control: 7.0 μL of XO buffer solution (0.4 U/ mL) was added to 0.1 M phosphate buffer pH 7.8 (130.0 μL). The reaction mixture was then incubated at 37 0 C for 10 min. Then 70.0 μL of 40 µM xanthine buffer solution was added to the mixture and the absorbance was recorded spectrophotometrically at 295 nm at 37 0 C for 10 min. The blank solution contained 7 μL of phosphate buffer solution. The test was performed in triplicate. Sample test: 7.0 μL of XO buffer solution (0.4U/ mL) was added to a solution consisting of 0.1 M phosphate buffer, pH 7.8 (80.0 μL), and different concentrations of C. tricuspidata extract (25.0, 50.0, 75.0 and 100 μL) were treated in the same manner as the control. Four μL of phosphate buffer solution was used instead of XO solution (0.4 U) for blank tests. The test was performed in triplicate. Enzyme inhibitory activity was determined by quantifying the amount of uric acid formation from xanthine in the reaction mixture. The assay mixture contained both C. tricuspidata extract and xanthine in order to have equal competition of the substrate and inhibitor for the enzyme active site. Both the inhibitor and substrate concentrations were maintained identically for the reaction. XO activity was expressed as % inhibition of XO, calculated as (1-B/A) X100, where A is the change in absorbance of the assay without the C. tricuspidata samples. (∆ Abs with enzyme -∆ Abs without enzyme), and B is the change in absorbance of the assay with the C. tricuspidata samples (∆ Abs with enzyme -∆ Abs without enzyme). The enzyme kinetics were similar to the XO assay method, which was expressed in terms of V max and K m [29, 32] .
